Arch Biopartners is developing next-generation drug candidates that target IL-32, a cytokine implicated in diabetic kidney disease as described in Dr. Chun’s new publication. The goal is to produce a ...

Scientists in the Blavatnik Institute at Harvard Medical School and MIT have created a new family of tools that, for the ...

Clonal cytopenias of undetermined significance often manifest prior to myelodysplastic syndromes (MDS), and a recent study found similarities in the cytokine profiles of the distinct conditions. In ...

ImmuneSensor Therapeutics, a clinical-stage biotherapeutics company focused on the development of first- and best-in-class cGAS inhibitors to address diverse peripheral and CNS indications in ...

Cytokines are chemical messengers that help the body get rid of invading bacteria and viruses, and control inflammation. The body carefully balances cytokines because they help keep the immune system ...

Asthma affects millions of people worldwide, and adult women experience the condition more frequently—and often more severely ...

In a recent open-access paper published in the Journal of Clinical Medicine, researchers from Iran and Germany show that high baseline levels of inflammatory cytokines measured during admission put ...

A high cytokine cluster was identified that was linked to more severe disease and high concentrations of anti-inflammatories such as IL-10, IL-2R, TNF-RII, and sTNFr1. Patients with sepsis with high ...

Rheumatoid arthritis is a common chronic inflammatory and destructive arthropathy that cannot be cured and that has substantial personal, social, and economic costs. The long-term prognosis is poor: ...

Researchers studying chronic inflammation that can lead to the development of lung diseases such as asthma, pulmonary fibrosis, and cancer, are focusing on the role cytokines play in regulating the ...